BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026.
World J Meta-Anal. Sep 18, 2026; 14(3): 120937
Published online Sep 18, 2026. doi: 10.13105/wjma.120937
Table 1 Causes of cholestatic pruritus
Etiology
Examples
Typical features
AutoimmunePBC, PSCChronic, nocturnal pruritus
GeneticPFIC, ALGSSevere, early onset
HormonalICPThird trimester
Drug-inducedAntibiotics, anabolic steroidsTemporal association
ObstructiveMalignancy, stonesJaundice-predominant
Table 2 Diagnostic tools and biomarkers
Tool
Utility
Limitations
Serum bile acidsReflect cholestasisPoor correlation with symptom severity
AutotaxinEmerging biomarker for cholestatic pruritusLimited availability; not standardized
5-D Itch ScaleAssesses multidimensional symptom severitySubjective patient-reported measure
ImagingExclude biliary obstruction or malignancyDoes not quantify itch severity
Table 3 Pharmacologic therapies for cholestatic pruritus
Therapy
Mechanism
Evidence
Key adverse effects
CholestyramineBile acid bindingLowGI intolerance
RifampinPXR inductionStrongHepatotoxicity
NaltrexoneOpioid blockadeModerateWithdrawal symptoms
SertralineCentral modulationLow-moderateSexual dysfunction, weight gain
FibratesPPAR activatorStrong (recent)Myalgia, transaminitis
IBAT inhibitorsBA circulation blockadeStrong (recent)Diarrhea
Table 4 Emerging and advanced therapies
Therapy
Population studied
Clinical role
OdevixibatPFIC, ALGSRefractory pruritus
MaralixibatALGSPediatric cholestasis
LinerixibatPBCAdult cholestasis
FibratesPBC, PSC, SSCCholestatic pruritus
UVB phototherapyMixed etiologiesAdjunctive


Write to the Help Desk